Torrent acquires Indian dermatological drugmaker Zyg

By Dan Stanton

- Last updated on GMT

Related tags States and territories of india

Torrent acquires Indian dermatological drugmaker Zyg
Torrent Pharma has added two facilities to its network through the acqusition of Zyg Pharma from the Encore Group.

India’s Torrent Pharma announced in May it had entered into an agreement with the Encore Group to buy the dermatological drugmaker Zyg Pharma, and on Thursday the deal was completed.

The addition sees Torrent support its strategy to strengthen its position in niche dermatologicals in developed markets such as the US and Europe, which it will do through the addition of two manufacturing facilities in Pithampur, Indore, approved by regulators including the US FDA and Asutralia’s TGA.

The site manufactures its own creams, ointments, gels, lotions and solutions for export, as well as having some commercial contract manufacturing space.

Torrent has three existing facilities: an API and finished formulation plant at Indrad in the Gujarat region, an oral dosage form site in Baddi in Himachal Pradesh, and a WHO approved facility in Sikkim. The Indrad plant has been making insulin exclusively for Novo Nordisk for over 15 years.

Related news

Show more

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...